Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco

被引:10
作者
Dakka, Nadia [1 ]
Bellaoui, Hicham
Khattab, Mohammed
Brahimi-Horn, Marie C.
Aoued, Leila
Bouzid, Nadia
Bakri, Youssef
Benjouad, Abdelaziz
机构
[1] Univ Mohammed 5, Fac Sci, Lab Biochim Immunol, Rabat, Morocco
[2] CNRST, UATRS, Serv Anal Biol, Rabat, Morocco
[3] Hop Enfants, Serv Pediat 2, Rabat, Morocco
关键词
immunophenotyping; acute lymphoblastic leukemia; children; diagnosis; prognostic factors;
D O I
10.1097/MPH.0b013e3181256b8f
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunophenotyping in leukemia offers a precise delineation of the hernatopoietic lineage and differentiation stage of the malignant cell. In this study, we used flow cytometry to determine the frequency of the immunologic types of acute lymphoblastic leukemia (ALL) in Moroccan children. We analyzed 100 samples from ALL patients within an age ranging from 6 months to 16 years presented over a 4-year period (1996 to 2000). Immunophenotyping allowed classification into 2 major categories: T-ALL (37%) and B-ALL (63%), with a higher percentage of males (69%). Comparison of the clinical characteristics showed that the frequency of splenomegaly was similar in B-ALL and T-ALL patients (53% and 47%, respectively). Hepatomegaly and mediastinal masses were more often associated with T-ALL (62% and 71%, respectively). Splenomegaly, hepatomegaly, and mediastinal masses were more frequent in immature than mature B-ALL, whereas the reverse was observed for T-ALL. Complete remission was obtained in 88% and 84% of B-ALL and T-ALL, respectively and relapse after 1 year occurred in 30% and 37% of cases, respectively. CD10 expressing B-ALL showed a slightly higher complete remission rate, whereas the reverse was observed for CD10 expressing T-ALL. The overall 5-year survival rate of ALL was 38%, whereas patients with B-ALL showed better survival than children with T-ALL.
引用
收藏
页码:574 / 580
页数:7
相关论文
共 42 条
  • [1] ARGARWAL B, 2003, TREATMENT ACUTE LEUK, P321
  • [2] USE OF IMMUNOPHENOTYPE AS PART OF THE PROGNOSTIC STRATIFICATION FOR CHILDHOOD ALL IN THE FRALLE-93 PROTOCOL
    BARUCHEL, A
    LEVERGER, G
    SCHAISON, G
    [J]. LEUKEMIA & LYMPHOMA, 1994, 13 : 91 - 93
  • [3] Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: Comparison with flow cytometric immunophenotyping
    Bavikatty, NR
    Ross, CW
    Finn, WG
    Schnitzer, B
    Singleton, TP
    [J]. HUMAN PATHOLOGY, 2000, 31 (09) : 1051 - 1054
  • [4] The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias
    Bene, MC
    Bernier, M
    Casasnovas, RO
    Castoldi, G
    Knapp, W
    Lanza, F
    Ludwig, WD
    Matutes, E
    Orfao, A
    Sperling, C
    van't Veer, MB
    [J]. BLOOD, 1998, 92 (02) : 596 - 599
  • [5] Immunophenotyping of acute leukaemias
    Béné, MC
    [J]. IMMUNOLOGY LETTERS, 2005, 98 (01) : 9 - 21
  • [6] BENE MC, 1995, LEUKEMIA, V9, P1783
  • [7] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) : 451 - &
  • [8] CD4/CD8-lineage differentiation in the thymus: From nuclear effectors to membrane signals
    Bosselut, R
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 529 - 540
  • [9] BRAYLAN RC, 2001, CYTOMETRY, V46, P119
  • [10] CD1: Antigen presentation and T cell function
    Brigl, M
    Brenner, MB
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 : 817 - 890